Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Anixa Biosciences ( (ANIX) ) is now available.
On March 10, 2026, Anixa Biosciences, Inc. held its 2026 annual meeting of stockholders, with 20.8 million of 33.4 million eligible common shares present or represented by proxy. Shareholders re-elected directors Amit Kumar, Arnold Baskies, Emily Gottschalk and Lewis H. Titterton, Jr. to serve until the 2027 annual meeting.
Investors also approved, on a non-binding advisory basis, the company’s executive compensation package and ratified Haskell & White LLP as independent registered public accounting firm for the fiscal year ending October 31, 2026. The voting outcomes indicate continued shareholder support for the company’s current leadership, pay practices and audit oversight structure.
The most recent analyst rating on (ANIX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Anixa Biosciences stock, see the ANIX Stock Forecast page.
Spark’s Take on ANIX Stock
According to Spark, TipRanks’ AI Analyst, ANIX is a Neutral.
Anixa Biosciences faces significant financial challenges, primarily due to its inability to generate revenue and persistent losses, which are compounded by negative cash flows. While its technical indicators show some positive momentum, the negative P/E ratio and lack of dividends make valuation unattractive. The company’s financial performance is the primary concern, overshadowing technical and valuation aspects.
To see Spark’s full report on ANIX stock, click here.
More about Anixa Biosciences
Anixa Biosciences, Inc. is a publicly traded company in the biotechnology and life sciences sector. The company’s shares are held by a broad base of stockholders, with over 33 million shares of common stock entitled to vote at its 2026 annual meeting, underscoring an established presence in public capital markets.
Average Trading Volume: 246,007
Technical Sentiment Signal: Sell
Current Market Cap: $99.91M
See more insights into ANIX stock on TipRanks’ Stock Analysis page.

